Funds holding Santen Pharmaceutical Co. Ltd
ISIN US80287P1003 · Japan · LEI 529900TPT3I7C17MIM03
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 630.5K $
A single tracked fund declares this company. So these figures do not say who owns it.
This issuer has other securities : Santen Pharmaceutical Co Ltd (JP3336000009)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Advisors Capital International Fund NEIMAN FUNDS | 56,700 | 630.5K $ | 1.36 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Advisors Capital International Fund NEIMAN FUNDS | 1.36 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 56,700 | 0.0 % |
| 2026Q1 | 1 | 0 | 56,700 | +18.9 % |
| 2025Q4 | 1 | 0 | 47,700 | +48.6 % |
| 2025Q3 | 1 | 0 | 32,100 | +154.8 % |
| 2025Q2 | 1 | 0 | 12,600 | +293.8 % |
| 2025Q1 | 1 | 0 | 3,200 | -92.0 % |
| 2024Q2 | 1 | 0 | 40,231 | +1,105.2 % |
| 2024Q1 | 1 | 3,338 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | 333 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Santen Pharmaceutical Co. Ltd". https://titelia.com/en/stocks/santen-pharmaceutical-co-ltd-US80287P1003